Crossmark

Trajectories of switching to optimise efficacy and minimising risks in patients with moderate-to-severe plaque psoriasis: results from the PsoReal registry

Crossref DOI link: https://doi.org/10.1007/s00403-024-02967-5

Published Online: 2024-05-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pezzolo, Elena https://orcid.org/0000-0003-0121-4812
Cazzaniga, Simone https://orcid.org/0000-0001-8161-6138
Cassalia, Fortunato https://orcid.org/0000-0002-5014-1122
Di Leo, Sara https://orcid.org/0000-0001-8668-2388
Naldi, Luigi https://orcid.org/0000-0002-3160-2835
License Information

Text and Data Mining valid from 2024-05-25

Version of Record valid from 2024-05-25
More Information

Article History

Received: 3 March 2024

Revised: 22 April 2024

Accepted: 26 April 2024

First Online: 25 May 2024

Declarations

:

: The authors declare no conflict of interest.

: No recognizable patient photographs or other identifiable material was included.

Document is current

Any future updates will be listed below